Pay in 4 interest-free payments of $5.78 Learn more
Ships within 48 hours · Estimated delivery Nov 6 - Nov 11
Based on the title and abstract, 64 articles were excluded, resulting in 93 articles eligible for full-text screening
The shortage of supply of GLP-1 therapies in South Africa is said to be caused by the rise in demand for their off-label use
The patent expiry is expected to trigger the entry of multiple Indian pharmaceutical companies into the market with lower-cost versions of semaglutide, the active ingredient in both drugs
Patients should not use peptides to push through a worsening injury
Healthcare professionals should educate patients on these dangers and discourage them from purchasing or using compounded semaglutide
US$ 26.98
US$ 26.03
US$ 26.89
US$ 27.76
US$ 25.73
US$ 28.70
US$ 29.39
